PROLIFERATION, MIGRATION AND INVASION OF HUMAN GLIOMA-CELLS EXPOSED TO ANTIFOLATE DRUGS

Citation
Aja. Terzis et al., PROLIFERATION, MIGRATION AND INVASION OF HUMAN GLIOMA-CELLS EXPOSED TO ANTIFOLATE DRUGS, International journal of cancer, 54(1), 1993, pp. 112-118
Citations number
23
Categorie Soggetti
Oncology
ISSN journal
00207136
Volume
54
Issue
1
Year of publication
1993
Pages
112 - 118
Database
ISI
SICI code
0020-7136(1993)54:1<112:PMAIOH>2.0.ZU;2-K
Abstract
The present study describes the effects of 2 folate antagonists, metho trexate (MTX) and the lipophilic antifolate trimetrexate (TMX) on 2 pe rmanent human glioma cell lines (GaMg and D-54Mg) grown as monolayers and as multicellular tumor spheroids. In addition, the effects of drug exposure on tumor cell invasion was studied using a three-dimensional organ co-culture system. in monolayer cultures, TMX was a more potent inhibitor of cell growth than MTX, especially towards the GaMg cell l ine. The 2 drugs, however, showed similar cytotoxicity as assessed by the plating efficiency assay. Reduced ability of directional migration of cells on a plastic surface was seen by either antifolate usually a t concentrations to 10-fold higher than those exerting a cytotoxic eff ect in the plating efficiency assay. TMX was somewhat more potent than MTX as an inhibitor of spheroid growth. When tumor spheroids were exp osed to MTX or TMX at concentrations that caused 65 to 70% inhibition of cell migration, there was a latent period of 4 to 5 days before inh ibition of spheroid growth ensued. Invasion was investigated in a co-c ulture system, where tumor spheroids were confronted with fetal rat br ain cell aggregates. Neither drug reduced tumor cell invasion, althoug h histological examination revealed toxic effects both in GaMg and in D-54Mg spheroids. We conclude that spheroids from human glioma cells w ere less sensitive to the antifolates than monolayers. For both drugs a latency period was observed before inhibition of spheroid growth. Th e spheroids retained their ability to invade normal brain tissue when exposed to levels of folate antagonists inhibiting spheroid growth.